Technology
Canada's Life Sciences at a Crossroads: Industry Leaders Clash on Growth Strategy
Canada's life sciences sector faces a critical choice: strategic government support or market-driven competition....
4 results
Canada's life sciences sector faces a critical choice: strategic government support or market-driven competition....
Toronto biotech firm Biossil raises $70M USD to resurrect failed drug candidates using AI—aiming to bring therapies...
Mountain Valley MD closes $2M financing round with strategic investors, issuing 80 million units to strengthen balance...
Ottawa commits $79M to Vancouver's Aspect Biosystems, backing a $280M effort to bring 3D-printed human tissue therapies...